Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances

Autophagy is a crucial general survival tactic of mammalian cells. It describes the capability of cells to disassemble and partially recycle cellular components (e.g., mitochondria) in case they are damaged and pose a risk to cell survival or simply if their resources are urgently needed elsewhere a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ingo Ganzleben, Markus F. Neurath, Christoph Becker
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/7fafd0c438094b7bb78e626e620dd514
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7fafd0c438094b7bb78e626e620dd514
record_format dspace
spelling oai:doaj.org-article:7fafd0c438094b7bb78e626e620dd5142021-11-11T15:35:45ZAutophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances10.3390/cancers132155752072-6694https://doaj.org/article/7fafd0c438094b7bb78e626e620dd5142021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5575https://doaj.org/toc/2072-6694Autophagy is a crucial general survival tactic of mammalian cells. It describes the capability of cells to disassemble and partially recycle cellular components (e.g., mitochondria) in case they are damaged and pose a risk to cell survival or simply if their resources are urgently needed elsewhere at the time. Autophagy-associated pathomechanisms have been increasingly recognized as important disease mechanisms in non-malignant (neurodegeneration, diffuse parenchymal lung disease) and malignant conditions alike. However, the overall consequences of autophagy for the organism depend particularly on the greater context in which autophagy occurs, such as the cell type or whether the cell is proliferating. In cancer, autophagy sustains cancer cell survival under challenging, i.e., resource-depleted, conditions. However, this leads to situations in which cancer cells are completely dependent on autophagy. Accordingly, autophagy represents a promising yet complex target in cancer treatment with therapeutically induced increase and decrease of autophagic flux as important therapeutic principles.Ingo GanzlebenMarkus F. NeurathChristoph BeckerMDPI AGarticleautophagymitophagyglutaminecancerreverse Warburg effecthydroxychloroquineNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5575, p 5575 (2021)
institution DOAJ
collection DOAJ
language EN
topic autophagy
mitophagy
glutamine
cancer
reverse Warburg effect
hydroxychloroquine
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle autophagy
mitophagy
glutamine
cancer
reverse Warburg effect
hydroxychloroquine
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ingo Ganzleben
Markus F. Neurath
Christoph Becker
Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
description Autophagy is a crucial general survival tactic of mammalian cells. It describes the capability of cells to disassemble and partially recycle cellular components (e.g., mitochondria) in case they are damaged and pose a risk to cell survival or simply if their resources are urgently needed elsewhere at the time. Autophagy-associated pathomechanisms have been increasingly recognized as important disease mechanisms in non-malignant (neurodegeneration, diffuse parenchymal lung disease) and malignant conditions alike. However, the overall consequences of autophagy for the organism depend particularly on the greater context in which autophagy occurs, such as the cell type or whether the cell is proliferating. In cancer, autophagy sustains cancer cell survival under challenging, i.e., resource-depleted, conditions. However, this leads to situations in which cancer cells are completely dependent on autophagy. Accordingly, autophagy represents a promising yet complex target in cancer treatment with therapeutically induced increase and decrease of autophagic flux as important therapeutic principles.
format article
author Ingo Ganzleben
Markus F. Neurath
Christoph Becker
author_facet Ingo Ganzleben
Markus F. Neurath
Christoph Becker
author_sort Ingo Ganzleben
title Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
title_short Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
title_full Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
title_fullStr Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
title_full_unstemmed Autophagy in Cancer Therapy—Molecular Mechanisms and Current Clinical Advances
title_sort autophagy in cancer therapy—molecular mechanisms and current clinical advances
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/7fafd0c438094b7bb78e626e620dd514
work_keys_str_mv AT ingoganzleben autophagyincancertherapymolecularmechanismsandcurrentclinicaladvances
AT markusfneurath autophagyincancertherapymolecularmechanismsandcurrentclinicaladvances
AT christophbecker autophagyincancertherapymolecularmechanismsandcurrentclinicaladvances
_version_ 1718435190205841408